Danone SA reported a notable uptick in sales during Q2, driven largely by the sustained popularity of its high-protein yogurts and fortified drinks tailored for the elderly and ill.

The French multinational’s focus on protein‑rich dairy products has resonated with health‑conscious consumers, boosting retail volumes across key markets. At the same time, its medical nutrition line—designed to support patients with limited appetite or specific dietary needs—has seen increased demand, particularly$route: the global shift toward preventive and supportive healthcare.

Financial analysts highlight that Danone’s strategy of blending everyday nutrition with specialized medical offerings positions the company well in a market that values both convenience and functional benefits. The company’s Q2 performance underscores the strength of this dual‑approach model.

Looking ahead, Danone plans to expand its product pipeline with new high‑protein, low‑sugar variants and further invest in research for age‑specific nutrition solutions, aiming to sustain momentum as consumer preferences continue to evolve toward more targeted, health‑centric choices.